Elisa Damo
elisadamo.bsky.social
Elisa Damo
@elisadamo.bsky.social
🇮🇹 Neurobiologist | Postdoc at NYU Pain Research Center
Reposted by Elisa Damo
Huge thanks to everyone who joined the #PRC Lunch at #SfN — inspiring conversations and incredible research collaborations emerged! 🙌🧠 #PRCmembers #SfN #SanDiego #circleJLabs @sfn.org @sdavidson.bsky.social @pazduran.bsky.social @elisadamo.bsky.social
November 19, 2025 at 4:26 PM
Reposted by Elisa Damo
PRIMED Speaker Blake Kimmey (UPenn) Paging the PAG: Pain, Opioids & Relief. Epic talk on Periaqueductal gray opioid circuits for pain aversion & relief. Blake broke down how brain circuits in the PAG decide what hurts and what doesn’t. Stress, booze, and opioids all play a part!
October 10, 2025 at 6:43 PM
Reposted by Elisa Damo
Excited to share my first senior author paper in Pain! 🎉 We identify Synaptojanin 1 & Endophilin A1 as key endocytic mediators of nociception. Silencing them blocks spinal synaptic transmission and relieves pain in cancer & postoperative models, without affecting normal behavior.
buff.ly/caKMGY3
buff.ly
June 11, 2025 at 5:25 PM
Reposted by Elisa Damo
And just like that, AMPIRS takes its final bow! 🎬Huge cheers to our grand finale presenters and a confetti cannon 🎉 of congrats to all the Flash Talk, Poster and Oral Presentation champs! 🏆 You dazzled, you delivered, you definitely deserve it! #PRCpride #MPBpride
May 31, 2025 at 1:25 AM
Reposted by Elisa Damo
Curtains down on AMPIRS! Dr. Nigel Bunnett, our MPB Chair, brought it home with closing remarks. Huge thanks to our amazing sponsors and a special shoutout to MPB for hosting AMPIRS & Welcoming the Pain Research Center into the fun! And now… cue the real research question: Wheres happy hour? 🍹😄
May 31, 2025 at 2:17 AM
Reposted by Elisa Damo
@tedpricethepainguy.bsky.social @utdpaincenter.bsky.social Great visit today from Dr. Ted Price! Thank you for wowing us with your team’s exciting data on human DRG tissue, very inspiring and insightful seminar! #painresearch #dorsalrootganglia #humanDRG #nyudental #nyuniversity #nyupainresearch
February 19, 2025 at 6:53 PM
Reposted by Elisa Damo
Neuropilin-1 (NRP1) is a co-receptor for NGF/TrkA pain signaling. Inhibiting NRP1 can reduce nociceptor activation and NGF-related pain. This important finding by the Bunnett lab and colleagues could lead to a non-opioid alternative for chronic pain treatment. www.jci.org/articles/vie...
JCI - NEUROPILIN-1 INHIBITION SUPPRESSES NERVE-GROWTH FACTOR SIGNALING AND NOCICEPTION IN PAIN MODELS
www.jci.org
December 18, 2024 at 4:10 PM
Reposted by Elisa Damo
Check out the latest article in my newsletter: Neuropilin-1: A New Frontier in Chronic Pain Management www.linkedin.com/pulse/neurop... via @LinkedIn
Neuropilin-1: A New Frontier in Chronic Pain Management
Summary Recent research highlights neuropilin-1 (NRP1) as a critical co-receptor for nerve growth factor (NGF) and TrkA signaling in pain mechanisms. While NGF monoclonal antibodies have shown promise...
www.linkedin.com
December 6, 2024 at 6:02 PM